Recursion Pharmaceuticals, Inc. (RXRX)
4.36
+0.41
(+10.38%)
USD |
NASDAQ |
Oct 09, 16:00
4.405
+0.04
(+1.03%)
After-Hours: 20:00
Recursion Pharmaceuticals 30-Day Average Daily Volume : 24.55M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 24.55M |
| October 08, 2026 | 23.73M |
| October 07, 2026 | 23.13M |
| October 06, 2026 | 22.53M |
| October 05, 2026 | 20.66M |
| October 02, 2026 | 19.18M |
| October 01, 2026 | 19.27M |
| September 30, 2026 | 19.70M |
| September 29, 2026 | 19.15M |
| September 28, 2026 | 18.79M |
| September 25, 2026 | 18.70M |
| September 24, 2026 | 18.71M |
| September 23, 2026 | 18.41M |
| September 22, 2026 | 17.99M |
| September 21, 2026 | 17.11M |
| September 18, 2026 | 16.16M |
| September 17, 2026 | 15.18M |
| September 16, 2026 | 14.82M |
| September 15, 2026 | 15.04M |
| September 14, 2026 | 15.14M |
| September 11, 2026 | 15.08M |
| September 10, 2026 | 15.16M |
| September 09, 2026 | 15.40M |
| September 08, 2026 | 15.74M |
| September 04, 2026 | 15.97M |
| Date | Value |
|---|---|
| September 03, 2026 | 15.55M |
| September 02, 2026 | 15.72M |
| September 01, 2026 | 15.76M |
| August 31, 2026 | 15.92M |
| August 28, 2026 | 16.15M |
| August 27, 2026 | 16.44M |
| August 26, 2026 | 17.41M |
| August 25, 2026 | 17.63M |
| August 24, 2026 | 17.73M |
| August 21, 2026 | 18.05M |
| August 20, 2026 | 17.98M |
| August 19, 2026 | 18.00M |
| August 18, 2026 | 17.75M |
| August 17, 2026 | 18.17M |
| August 14, 2026 | 19.08M |
| August 13, 2026 | 19.82M |
| August 12, 2026 | 20.65M |
| August 11, 2026 | 21.08M |
| August 10, 2026 | 21.48M |
| August 07, 2026 | 22.43M |
| August 06, 2026 | 22.64M |
| August 05, 2026 | 22.66M |
| August 04, 2026 | 22.45M |
| August 03, 2026 | 22.22M |
| July 31, 2026 | 22.55M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Absci Corp. | 4.071M |
| Twist Bioscience Corp. | 2.642M |
| Editas Medicine, Inc. | 2.996M |
| Amgen, Inc. | 2.982M |
| Halozyme Therapeutics, Inc. | 2.288M |